Mildronate® GX Drug formulation: Active substance: meldonium phosphate; 1 tablet contains meldonium phosphate (in terms of meldonium) 500 mg; Adjuvants: mannitol (e 421), povidone k29/32, potato starch, silicon dioxide, microcrystalline cellulose, magnesium stearate; Indications. • decreased working efficiency, intellectual and physical overstress (including in athletes); • for combined therapy of ischemic heart disease (stenocardia, myocardial infarction), chronic cardiac decompensation, and dyshormonal cardiomyopathy; • for combined therapy of chronic disturbances of brain blood supply (cerebral strokes, and cerebrovascular insufficiency); • diseases of peripheral arteries (DP A); • abstinence syndrome in case of chronic alcoholism (in combination with specific alcoholism therapy). Contraindications. Hypersensitivity to meldonium or any components of the drug. Increased intracranial pressure (in case of impaired venous drainage, intracranial tumours). Pregnancy and breast-feeding periods. Children's age.
Trustpilot
1 month ago
3 weeks ago
